NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy
Applied Biochemistry and Biotechnology · 2026-12 · 198 (12) · 10685-10710
DOI: 10.1007/s12010-026-05931-3 ↗At a glance
Journal article in Applied Biochemistry and Biotechnology, published online on 2026-09-23. Written by Hai Bai and 4 co-authors. Institution: Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China. Major MEDLINE topics: Immunotherapy, Neoplasms, Biomarkers, Tumor, Nuclear Proteins. 41 references. Funded by: National Natural Science Foundation of China.
Abstract (original language)
Santrauka nepasiekiama.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Institute of Applied Biotechnology, College of Agronomy and Life Science, Shanxi Datong University, Datong, Shanxi province, 037009, PR China.
- Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China.
- Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China.
- Department of Physiology, School of Basic Medicine and Life Sciences, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, PR China. wmm@xzhmu.edu.cn.
- Xuzhou Key Laboratory of Physiological Function and Injury, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.
- National Experimental Teaching Demonstration Center for Basic Medicine, Xuzhou Medical University, Xuzhou, Jiangsu Province, 221004, P.R. China. wmm@xzhmu.edu.cn.
Funding
- National Natural Science Foundation of China
Cite
APA
Bai, H., Xu, W., Wei, G., Cao, Y., & Wang, M. (2026). NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology, 198(12), 10685-10710. https://doi.org/10.1007/s12010-026-05931-3
Vancouver
Bai H, Xu W, Wei G, Cao Y, Wang M. NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy. Applied Biochemistry and Biotechnology. 2026;198(12):10685-10710. doi:10.1007/s12010-026-05931-3
BibTeX
@article{Bai2026,
author = {Bai, Hai and Xu, Wanqing and Wei, Guozheng and Cao, Yue and Wang, Mingming},
title = {NOC4L: An Emerging Dual-Action Target for Cancer Prognosis and Immunotherapy},
journal = {Applied Biochemistry and Biotechnology},
year = {2026},
volume = {198},
number = {12},
pages = {10685--10710},
doi = {10.1007/s12010-026-05931-3}
}
EUVIMED